{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:44:24Z","timestamp":1768423464992,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s13353-024-00831-w","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:02:37Z","timestamp":1705996957000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacogenetic study of CES1 gene and enalapril efficacy"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8825-917X","authenticated-orcid":false,"given":"Misbah","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sehrish","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adila","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qurat Ul Ain","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Faizan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"issue":"1","key":"831_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-2-4","volume":"2","author":"RC Alencar","year":"2010","unstructured":"Alencar RC, Cobas RA, Gomes MB (2010) Allergic reaction related to ramipril use: a case report. Diabetol Metab Syndr 2(1):1\u20134","journal-title":"Diabetol Metab Syndr"},{"key":"831_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2019.11.086","volume":"306","author":"SH Ann","year":"2020","unstructured":"Ann SH, Strauss MH, Park G-M, Han S, Yang Y, Kim Y-G, Won K-B, Kim S-J, Lee S-G, Cho Y-R (2020) Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention. Int J Cardiol 306:35\u201341","journal-title":"Int J Cardiol"},{"issue":"5","key":"831_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/tpj.2012.25","volume":"13","author":"E Bruxel","year":"2013","unstructured":"Bruxel E, Salatino-Oliveira A, Genro J, Zeni C, Polanczyk G, Chazan R, Rohde L, Hutz M (2013) Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit\/hyperactivity disorder treated with methylphenidate. Pharmacogenomics J 13(5):476\u2013480","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"831_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/phar.1194","volume":"33","author":"S Casey Laizure","year":"2013","unstructured":"Casey Laizure S, Herring V, Hu Z, Witbrodt K, Parker RB (2013) The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy 33(2):210\u2013222","journal-title":"Pharmacotherapy"},{"issue":"1","key":"831_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12793\/tcp.2014.22.1.30","volume":"22","author":"Y-J Cha","year":"2014","unstructured":"Cha Y-J, Jeong H-E, Shin J-G, Kim E-Y, Yu K-S, Cho J-Y, Yoon SH, Lim KS (2014) Genetic polymorphisms of the carboxylesterase 1 (CES1) gene in a Korean population. Transl Clin Pharmacol 22(1):30\u201334","journal-title":"Transl Clin Pharmacol"},{"issue":"3","key":"831_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","volume":"78","author":"R Chen","year":"2021","unstructured":"Chen R, Suchard MA, Krumholz HM, Schuemie MJ, Shea S, Duke J, Pratt N, Reich CG, Madigan D, You SC (2021) Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension 78(3):591\u2013603","journal-title":"Hypertension"},{"issue":"10","key":"831_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/s41374-018-0032-9","volume":"98","author":"BG Durgin","year":"2018","unstructured":"Durgin BG, Straub AC (2018) Redox control of vascular smooth muscle cell function and plasticity. Lab Invest 98(10):1254\u20131262","journal-title":"Lab Invest"},{"issue":"776","key":"831_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/pgmj.66.776.446","volume":"66","author":"M El Mangoush","year":"1990","unstructured":"El Mangoush M, Singh N, Kumar S, Basha A, Gupta B, Bolya Y, Gamati A (1990) Efficacy of enalapril in essential hypertension and its comparison with atenolol. Postgrad Med J 66(776):446\u2013449","journal-title":"Postgrad Med J"},{"key":"831_CR9","unstructured":"Faruqi A, Jain A (2021) Enalapril. StatPearls, StatPearls Publishing"},{"issue":"10","key":"831_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/FPC.0b013e32830b0c5e","volume":"18","author":"T Fukami","year":"2008","unstructured":"Fukami T, Nakajima M, Maruichi T, Takahashi S, Takamiya M, Aoki Y, McLeod HL, Yokoi T (2008) Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes. Pharmacogenet Genomics 18(10):911\u2013920","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"831_CR11","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.apsb.2022.10.017","volume":"13","author":"C Gan","year":"2023","unstructured":"Gan C, Wang J, Mart\u00ednez-Ch\u00e1vez A, Hillebrand M, de Vries N, Beukers J, Wagenaar E, Wang Y, Lebre MC, Rosing H (2023) Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism. Acta Pharm Sin B 13(2):618\u2013631","journal-title":"Acta Pharm Sin B"},{"key":"831_CR12","doi-asserted-by":"crossref","unstructured":"Gordon SG, Kittleson MD (2008) Chapter 17\u2014Drugs used in the management of heart disease and cardiac arrhythmias. In: Maddison JE, Page SW, Church DB (eds) Small Animal Clinical Pharmacology, 2nd edn. W.B. Saunders, Edinburgh, UK, pp 380\u2013457","DOI":"10.1016\/B978-070202858-8.50019-1"},{"issue":"3","key":"831_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/dmd.119.089680","volume":"48","author":"L Her","year":"2020","unstructured":"Her L, Zhu H-J (2020) Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators. Drug Metab Dispos 48(3):230\u2013244","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"831_CR14","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1111\/bcp.14888","volume":"87","author":"LH Her","year":"2021","unstructured":"Her LH, Wang X, Shi J, Choi HJ, Jung SM, Smith LS, Wu AH, Bleske BE, Zhu HJ (2021) Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects. Br J Clin Pharmacol 87(12):4691\u20134700","journal-title":"Br J Clin Pharmacol"},{"key":"831_CR15","unstructured":"Herman LL, Bashir K (2019) Angiotensin converting enzyme inhibitors (ACEI). In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL"},{"issue":"1","key":"831_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03602530600952164","volume":"39","author":"M Hosokawa","year":"2007","unstructured":"Hosokawa M, Furihata T, Yaginuma Y, Yamamoto N, Koyano N, Fujii A, Nagahara Y, Satoh T, Chiba K (2007) Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes. Drug Metab Rev 39(1):1\u201315","journal-title":"Drug Metab Rev"},{"issue":"4","key":"831_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/jpm12040580","volume":"12","author":"A Ikonnikova","year":"2022","unstructured":"Ikonnikova A, Rodina T, Dmitriev A, Melnikov E, Kazakov R, Nasedkina T (2022) The influence of the CES1 genotype on the pharmacokinetics of enalapril in patients with arterial hypertension. J Pers Med 12(4):580","journal-title":"J Pers Med"},{"issue":"6","key":"831_CR18","first-page":"219","volume":"8","author":"D Jennings","year":"2007","unstructured":"Jennings D, Kalus J, Coleman C, Manierski C, Yee J (2007) Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy-a meta-analysis. Clin Diabetol 8(6):219\u2013228","journal-title":"Clin Diabetol"},{"issue":"5","key":"831_CR19","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/bcp.14646","volume":"87","author":"Q Ji","year":"2021","unstructured":"Ji Q, Zhang C, Xu Q, Wang Z, Li X, Lv Q (2021) The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation. Br J Clin Pharmacol 87(5):2247\u20132255","journal-title":"Br J Clin Pharmacol"},{"issue":"17","key":"831_CR20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2217\/pgs-2019-0091","volume":"20","author":"A Labriet","year":"2019","unstructured":"Labriet A, L\u00e9vesque \u00c9, Mattia ED, Cecchin E, Jonker D, Couture F, Simonyan D, Buonadonna A, D\u2019Andrea M, Villeneuve L (2019) Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients. Pharmacogenomics 20(17):1179\u20131187","journal-title":"Pharmacogenomics"},{"issue":"8","key":"831_CR21","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/infdis\/jiaa447","volume":"222","author":"KW Lam","year":"2020","unstructured":"Lam KW, Chow KW, Vo J, Hou W, Li H, Richman PS, Mallipattu SK, Skopicki HA, Singer AJ, Duong TQ (2020) Continued in-hospital angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use in hypertensive COVID-19 patients is associated with positive clinical outcome. J Infect Dis 222(8):1256\u20131264","journal-title":"J Infect Dis"},{"issue":"1","key":"831_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FPC.0b013e32835aa8a2","volume":"23","author":"JP Lewis","year":"2013","unstructured":"Lewis JP, Horenstein RB, Ryan K, O\u2019Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US (2013) The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Pharmacogenet Genomics 23(1):1","journal-title":"Pharmacogenet Genomics"},{"key":"831_CR23","doi-asserted-by":"crossref","unstructured":"Li G, Li X, Mahmud I, Ysaguirre J, Fekry B, Wang S, Wei B, Eckel-Mahan KL, Lorenzi PL, Lehner R (2023) Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. JCI insight 8(2):e163624","DOI":"10.1172\/jci.insight.163624"},{"issue":"3","key":"831_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/dmdi-2014-0009","volume":"29","author":"Z Merali","year":"2014","unstructured":"Merali Z, Ross S, Par\u00e9 G (2014) The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect. Drug Metab Drug Interact 29(3):143\u2013151","journal-title":"Drug Metab Drug Interact"},{"issue":"7","key":"831_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/biom11070979","volume":"11","author":"GJ Moore","year":"2021","unstructured":"Moore GJ, Pires JM, Kelaidonis K, Gadanec LK, Zulli A, Apostolopoulos V, Matsoukas JM (2021) Receptor interactions of angiotensin II and angiotensin receptor blockers\u2014relevance to COVID-19. Biomolecules 11(7):979","journal-title":"Biomolecules"},{"issue":"12","key":"831_CR26","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/biomedicines11123323","volume":"11","author":"A Nagy","year":"2023","unstructured":"Nagy A, M\u00e1jer R, Bocz\u00e1n J, Sipka S Jr, Szab\u00f3 A, Enyedi EE, Tatai O, Fagyas M, Papp Z, Csiba L (2023) Enalapril is superior to lisinopril in improving endothelial function without a difference in blood\u2013pressure\u2013lowering effects in newly diagnosed hypertensives. Biomedicines 11(12):3323","journal-title":"Biomedicines"},{"issue":"10","key":"831_CR27","doi-asserted-by":"publisher","first-page":"100189","DOI":"10.1016\/j.xgen.2022.100189","volume":"2","author":"K Nam","year":"2022","unstructured":"Nam K, Kim J, Lee S (2022) Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits. Cell Genomics 2(10):100189","journal-title":"Cell Genomics"},{"issue":"4","key":"831_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/FPC.0000000000000203","volume":"26","author":"KE Nelveg-Kristensen","year":"2016","unstructured":"Nelveg-Kristensen KE, Madsen MB, Torp-Pedersen C, K\u00f8ber L, Egfjord M, Hansen T, Pedersen O, Rasmussen HB, Hansen PR (2016) Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitors. Pharmacogenet Genomics 26(4):169\u2013177","journal-title":"Pharmacogenet Genomics"},{"key":"831_CR29","doi-asserted-by":"crossref","unstructured":"Nzabonimpa GS, Rasmussen HB, Brunak S, Taboureau O, I. Consortium (2016)Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches. Drug Metab Pers Ther 31(2):97\u2013106","DOI":"10.1515\/dmpt-2015-0034"},{"key":"831_CR30","unstructured":"Organization WH (2021) Hypertension. Retrieved October 28, 2022, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension"},{"key":"831_CR31","unstructured":"Organization WH (2022) Noncommunicable diseases. Retrieved October 28, 2022, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases"},{"issue":"1","key":"831_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/FJC.0000000000000930","volume":"77","author":"S Park","year":"2021","unstructured":"Park S, Kim Y-G, Ann SH, Park HW, Suh J, Roh J-H, Cho Y-R, Han S, Park G-M (2021) Angiotensin-converting enzyme inhibitor\u2013based versus angiotensin receptor blocker\u2013based optimal medical therapy after percutaneous coronary intervention: a nationwide cohort study. J Cardiovasc Pharmacol 77(1):61\u201368","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"831_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ihj.2020.08.007","volume":"72","author":"B Pinto","year":"2020","unstructured":"Pinto B, Jadhav U, Singhai P, Sadhanandham S, Shah N (2020) ACEI-induced cough: a review of current evidence and its practical implications for optimal CV risk reduction. Indian Heart J 72(5):345\u2013350","journal-title":"Indian Heart J"},{"issue":"12","key":"831_CR34","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1161\/01.CIR.95.12.2652","volume":"95","author":"G Sambuceti","year":"1997","unstructured":"Sambuceti G, Marzilli M, Marraccini P, Schneider-Eicke J, Gliozheni E, Parodi O, L\u2019Abbate A (1997) Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 95(12):2652\u20132659","journal-title":"Circulation"},{"issue":"1","key":"831_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s43044-023-00398-7","volume":"75","author":"A Samir","year":"2023","unstructured":"Samir A, Aboel-Naga S, Shehata A, Abdelhamid M (2023) Telmisartan versus EnalapRil In heart failure with redUced ejection fraction patients with Moderately impaired kidney Functions; randomized controlled trial: \u201cTRIUMF trial\u201d. Egypt Heart J 75(1):68","journal-title":"Egypt Heart J"},{"issue":"5","key":"831_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/FPC.0000000000000206","volume":"26","author":"JC Sanford","year":"2016","unstructured":"Sanford JC, Wang X, Shi J, Barrie ES, Wang D, Zhu H-J, Sadee W (2016) Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus. Pharmacogenet Genomics 26(5):197","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"831_CR37","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2174\/092986609789071324","volume":"16","author":"SP Sanghani","year":"2009","unstructured":"Sanghani SP, Sanghani PC, Schiel MA, Bosron WF (2009) Human carboxylesterases: an update on CES1, CES2 and CES3. Protein Pept Lett 16(10):1207\u20131214","journal-title":"Protein Pept Lett"},{"key":"831_CR38","doi-asserted-by":"crossref","unstructured":"Sear JW (2019) Antihypertensive drugs and vasodilators. In: Hemmings HC, Egan TD (eds) Pharmacology and Physiology for Anesthesia Foundations and Clinical Application, 2nd edn. Saunders, Philadelphia, PA, USA, pp 535\u2013555","DOI":"10.1016\/B978-0-323-48110-6.00026-0"},{"issue":"6","key":"831_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bcpt.12625","volume":"119","author":"J Shi","year":"2016","unstructured":"Shi J, Wang X, Eyler RF, Liang Y, Liu L, Mueller BA, Zhu HJ (2016a) Association of oseltamivir activation with gender and carboxylesterase 1 genetic polymorphisms. Basic Clin Pharmacol Toxicol 119(6):555\u2013561","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"831_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bcp.2016.09.003","volume":"119","author":"J Shi","year":"2016","unstructured":"Shi J, Wang X, Nguyen J-H, Bleske BE, Liang Y, Liu L, Zhu H-J (2016b) Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender. Biochem Pharmacol 119:76\u201384","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"831_CR41","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1124\/dmd.115.068536","volume":"44","author":"J Shi","year":"2016","unstructured":"Shi J, Wang X, Nguyen J, Wu AH, Bleske BE, Zhu H-J (2016c) Sacubitril is selectively activated by carboxylesterase 1 (CES1) in the liver and the activation is affected by CES1 genetic variation. Drug Metab Dispos 44(4):554\u2013559","journal-title":"Drug Metab Dispos"},{"key":"831_CR42","doi-asserted-by":"crossref","unstructured":"Stage C, J\u00fcrgens G, Guski LS, Thomsen R, Bjerre D, Ferrero\u2010Miliani L, Lyauk YK, Rasmussen HB, Dalhoff K, I. Consortium (2017) The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects. Br J Clin Pharmacol 83(7):1506\u20131514","DOI":"10.1111\/bcp.13237"},{"issue":"6","key":"831_CR43","doi-asserted-by":"publisher","first-page":"e2554","DOI":"10.1097\/MD.0000000000002554","volume":"95","author":"W Sun","year":"2016","unstructured":"Sun W, Zhang H, Guo J, Zhang X, Zhang L, Li C, Zhang L (2016) Comparison of the efficacy and safety of different ACE inhibitors in patients with chronic heart failure: a PRISMA-compliant network meta-analysis. Medicine 95(6):e2554","journal-title":"Medicine"},{"key":"831_CR44","doi-asserted-by":"crossref","unstructured":"Swedberg K, Kjekshus J, C. T. S. Group (1988) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).Am J Cardiol 62(2):60A\u201366A","DOI":"10.1016\/S0002-9149(88)80087-0"},{"issue":"5","key":"831_CR45","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/bcp.12667","volume":"80","author":"EK Tarkiainen","year":"2015","unstructured":"Tarkiainen EK, Tornio A, Holmberg MT, Launiainen T, Neuvonen PJ, Backman JT, Niemi M (2015) Effect of carboxylesterase 1 c. 428G> A single nucleotide variation on the pharmacokinetics of quinapril and enalapril. Br J Clin Pharmacol 80(5):1131\u20131138","journal-title":"Br J Clin Pharmacol"},{"key":"831_CR46","doi-asserted-by":"crossref","unstructured":"Thomsen R, Rasmussen HB, Linnet K, I. Consortium (2014) In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.Drug Metab Dispos 42(1):126\u2013133","DOI":"10.1124\/dmd.113.053512"},{"issue":"3","key":"831_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/tpj.2015.42","volume":"16","author":"X Wang","year":"2016","unstructured":"Wang X, Wang G, Shi J, Aa J, Comas R, Liang Y, Zhu H-J (2016) CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors. Pharmacogenomics J 16(3):220\u2013230","journal-title":"Pharmacogenomics J"},{"issue":"11","key":"831_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1124\/dmd.117.077669","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Rida N, Shi J, Wu AH, Bleske BE, Zhu H-J (2017) A comprehensive functional assessment of carboxylesterase 1 nonsynonymous polymorphisms. Drug Metab Dispos 45(11):1149\u20131155","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"831_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","volume":"8","author":"D Wang","year":"2018","unstructured":"Wang D, Zou L, Jin Q, Hou J, Ge G, Yang L (2018) Human carboxylesterases: a comprehensive review. Acta Pharm Sin B 8(5):699\u2013712","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"831_CR50","doi-asserted-by":"publisher","first-page":"1800288","DOI":"10.1002\/pmic.201800288","volume":"19","author":"X Wang","year":"2019","unstructured":"Wang X, Shi J, Zhu HJ (2019) Functional study of carboxylesterase 1 protein isoforms. Proteomics 19(4):1800288","journal-title":"Proteomics"},{"issue":"19","key":"831_CR51","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 71(19):e127\u2013e248","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"831_CR52","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/j.1875-9114.1998.tb03121.x","volume":"18","author":"CM White","year":"1998","unstructured":"White CM (1998) Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors. Pharmacotherapy 18(3):588\u2013599","journal-title":"Pharmacotherapy"},{"issue":"3","key":"831_CR53","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1523-1755.2005.00145.x","volume":"67","author":"G Wolf","year":"2005","unstructured":"Wolf G, Ritz E (2005) Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 67(3):799\u2013812","journal-title":"Kidney Int"},{"issue":"1","key":"831_CR54","doi-asserted-by":"publisher","first-page":"7244","DOI":"10.1038\/s41598-017-07736-1","volume":"7","author":"F-Y Xiao","year":"2017","unstructured":"Xiao F-Y, Luo J-Q, Liu M, Chen B-L, Cao S, Liu Z-Q, Zhou H-H, Zhou G, Zhang W (2017) Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients. Sci Rep 7(1):7244","journal-title":"Sci Rep"},{"issue":"3","key":"831_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.bbrc.2008.02.120","volume":"369","author":"M Yoshimura","year":"2008","unstructured":"Yoshimura M, Kimura T, Ishii M, Ishii K, Matsuura T, Geshi E, Hosokawa M, Muramatsu M (2008) Functional polymorphisms in carboxylesterase1A2 (CES1A2) gene involves specific protein 1 (Sp1) binding sites. Biochem Biophys Res Commun 369(3):939\u2013942","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"831_CR56","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1124\/jpet.112.201640","volume":"344","author":"H-J Zhu","year":"2013","unstructured":"Zhu H-J, Wang X, Gawronski BE, Brinda BJ, Angiolillo DJ, Markowitz JS (2013) Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation. J Pharmacol Exp Ther 344(3):665\u2013672","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-024-00831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13353-024-00831-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-024-00831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T14:21:11Z","timestamp":1723126871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13353-024-00831-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s13353-024-00831-w","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}